摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Gly-His-Gly | 7758-33-0

中文名称
——
中文别名
——
英文名称
Gly-His-Gly
英文别名
2-[[2-[(2-azaniumylacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]acetate
Gly-His-Gly化学式
CAS
7758-33-0
化学式
C10H15N5O4
mdl
——
分子量
269.26
InChiKey
ADZGCWWDPFDHCY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    224℃
  • 沸点:
    856.7±65.0 °C(Predicted)
  • 密度:
    1.440

计算性质

  • 辛醇/水分配系数(LogP):
    -4.5
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    150
  • 氢给体数:
    5
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2933290090

SDS

SDS:9b5b8ef1845bb729b33e406b98d7c9bf
查看

反应信息

  • 作为反应物:
    描述:
    potassium tetrachloropalladate(II)Gly-His-Gly重水 为溶剂, 生成 [Pd(Gly-His-Gly-N,N',N3)Cl]
    参考文献:
    名称:
    含甲硫氨酸和组氨酸的四肽与不同的Pd(II)和Pt(II)配合物的反应的研究:通过肽的电镀和催化剂的空间修饰选择性地裂解酰胺键。
    摘要:
    (1)H NMR光谱用于研究[M(en)(H(2)O)(2)](2+)配合物(M = Pd(ii)和Pt(ii))与N-乙酰化的甲硫酰基-甘氨酰-组氨酸-甘氨酰胺,MeCOMet-Gly-His-GlyNH(2)。所有反应均在60℃下于1.5-2.0 pH范围内用等摩尔量的[M(en)(H(2)O)(2)](2+)配合物和四肽进行。与甲硫氨酸残基结合的金属(ii)配合物影响涉及甲硫氨酸羧基的酰胺键的区域选择性裂解。与该肽中的其他酰胺键相比,Met-Gly酰胺键的切割优先级归因于Pt(ii)和Pd(ii)离子对硫供体原子的高度亲和力。讨论了这些水解反应的机理,并为澄清起见,[Pd(en)(H(2)O)(2)](2+)配合物与MeCOMet-Gly-His-GlyNH(2)的反应还通过电位滴定法进行了研究。[Pd(L)(H(2)O)(2)](2+)类型的各种钯(ii)配合物的空间效应,其中L是
    DOI:
    10.1039/b908182h
点击查看最新优质反应信息

文献信息

  • C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0447547A1
    公开(公告)日:1991-09-25
    A C-terminus amidation enzyme composition of serum or blood plasma origin, which acts on a C-terminus glycine adduct represented by formula (I) (wherein A represents a residue other than α-amino or imino group and α-carboxyl group of a natural α-amino acid origin, and X represents a hydrogen atom or a residue of an amino acid derivative bound to the N atom via a carbonyl group) to produce a C-terminus amidation product represented by formula (II) (wherein A and X are as defined above) and glyoxylic acid, is disclosed. A process for preparing the composition and its use are also disclosed.
    一种来源于血清或血浆的 C-端酰胺化酶组合物,它作用于式(I)代表的 C-端甘酸加合物(其中 A 代表除天然 α-氨基酸来源的 α-基或亚胺基和 α-羧基以外的残基),X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基、和 X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基),以产生由式 (II) 代表的 C 端酰胺化产物(其中 A 和 X 如上定义)和乙醛酸。还公开了制备该组合物的工艺及其用途。
  • Enzyme participating in c-terminal amidation, and method of preparing same and use thereof
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0666318A1
    公开(公告)日:1995-08-09
    An enzyme catalyzing the conversion of a peptide C-terminal glycine adduct represented by the following formula (I): (wherein A represents a residue other than α-amino group or imino group and α-carboxylic group derived from naturally occurring α-amino acid, X represents hydrogen atom or a residue of an amino acid derivative which is bonded to N atom through carbonyl group) to a peptide C-terminal α-hydroxyglycine adduct represented by the following formula (II): (wherein A and X have the same meanings as above), and further catalyzing the conversion of the peptide C-terminal α-hydroxylglycine adduct represented by the above formula (II) to a C-terminal amidated compound represented by the following formula (III): (wherein A and X have the see meanings as defined above), which comprises culturing host cells transformed with an expression plasmid comprising a DNA coding for said enzyme, and recovering both or either of said enzymes from the culture, characterized in that in said DNA a portion corresponding to the membrane spanning region has been excised.
    催化下式(I)所代表的肽 C 端甘酸加合物转化的酶: (其中 A 代表α-基或亚胺基和α-羧基以外的残基,α-基或亚胺基和α-羧基来自天然存在的α-氨基酸,X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基)转化为下式(II)代表的肽 C-末端α-羟基甘酸加合物: (其中A和X的含义同上),并进一步催化由上式(II)代表的肽C-末端α-羟基甘酸加合物转化为由下式(III)代表的C-末端酰胺化化合物: (其中A和X的含义与上式相同),其中包括培养用包含编码上述酶的DNA的表达质粒转化的宿主细胞,并从培养物中回收上述两种或其中一种酶,其特征在于,在上述DNA中,对应于跨膜区的部分已被切除。
  • Method for producing of phthalocyanine compound
    申请人:NIPPON SHOKUBAI CO., LTD.
    公开号:EP0882768A2
    公开(公告)日:1998-12-09
    A method for producing a novel phthalocyanine compound which excels in yield and purity, allows no introduction of a chlorine atom into the phthalocyanine skeleton, and possesses relatively bulky substituents is provided. This method is characterized by causing an orthophthalonitrile compound having a substituent exhibiting smaller σp values than σm values in the Hammett's rule to react with a metal oxide in the presence of a compound forming in the aqueous solution thereof at 25°C an acid or conjugate acid having a dissociation index pKa (the logarithmic value of the reciprocal of the dissociation constant of the acid or conjugate acid) of not more than 7.0.
    本发明提供了一种生产新型酞菁化合物的方法,该方法产量高、纯度高,不允许在酞菁骨架中引入原子,并具有相对笨重的取代基。 该方法的特点是,在 25°C 时,在其溶液中形成的酸或共轭酸的化合物存在下,使具有取代基的 σp 值小于哈密特规则中的σm 值的邻苯二甲腈化合物与金属氧化物反应,该酸或共轭酸的离解指数 pKa(酸或共轭酸的离解常数倒数的对数值)不大于 7.0。
  • Enzyme participating in C-terminal amidation, and method of preparing same and use thereof
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0884389A1
    公开(公告)日:1998-12-16
    An enzyme participating in C-terminal amidation which acts on a peptide C-terminal glycine adduct represented by the following formula (I): (wherein A represents a residue other than α-amino group or imino group and α-carboxylic group derived from naturally occurring α-amino acid, X represents hydrogen atom or a residue of an amino acid derivative which is bonded to N atom through carbonyl group) to form a peptide C-terminal α-hydroxylglycine adduct represented by the following formula (II): (wherein A and X have the same meanings as above, and an enzyme participating in peptide C-terminal amidation of a peptide terminal glycine adduct which acts on a peptide C-terminal α-hydroxylglycine adduct represented by the above formula (II) to form a C-terminal amidated compound represented by the following formula (III): (wherein A and X have the same meanings as described above) a method of producing the same, and the use thereof.
    一种参与 C 端酰胺化的酶,它作用于由下式(I)代表的肽 C 端甘酸加合物: (其中 A 代表α-基或亚胺基和α-羧基以外的残基,X 代表氢原子或通过羰基与 N 原子结合的氨基酸生物残基),以形成下式(II)所代表的肽 C-末端α-羟基甘酸加合物: (其中 A 和 X 的含义同上,以及一种参与肽 C-末端甘酸加合物酰胺化的酶,该酶作用于上式(II)代表的肽 C-末端α-羟基甘酸加合物,形成下式(III)代表的 C-末端酰胺化化合物: (其中A和X的含义与上述相同)的生产方法及其用途。
  • Cellulose acetate and dope containing the same
    申请人:Daicel Chemical Industries, Ltd.
    公开号:EP0943626A1
    公开(公告)日:1999-09-22
    Using the dope containing the following cellulose acetate (1), (2), or (3), a film is prepared by the casting process: (1) a cellulose acetate having carboxyl groups binding to at least one member selected from the group consisting of a cellulose acetate and a hemicellulose acetate, wherein at least a part of said carboxyl groups are in an acidic form; (2) a cellulose acetate containing at least one member selected from the group consisiting of an acid having an acid dissociation exponent pKa of 1.93 to 4.50 in water, an alkali metal salt of said acid and an alkaline earth metal of said acid; or (3) a cellulose acetate containing an alkali metal or an alkaline earth metal wherein the total content of an alkaline metal and an alkaline earth metal in 1 gram of the cellulose acetate is from an effective amount to 5.5 x 10-6 equivalent (in terms of ion equivalent). The above cellulose acetate is also useful for spinning process. The cellulose acetate includes a cellulose diacetate and a cellulose triacetate. The cellulose acetate of the present invention has high film-releasability from a support and excellent optical characteristics.
    使用含有以下醋酸纤维素 (1)、(2) 或 (3) 的涂料,通过浇铸工艺制备薄膜: (1) 具有羧基的醋酸纤维素,羧基与至少一个选自醋酸纤维素醋酸纤维素的成员结合,其中至少一部分羧基呈酸性; (2) 含有至少一个成员的醋酸纤维素,该成员选自由在中的酸解离指数 pKa 为 1.93 至 4.50 的酸、所述酸的碱属盐和所述酸的碱土属组成的组;或 (3) 含有碱属或碱土属的醋酸纤维素,其中 1 克醋酸纤维素中碱属和碱土属的总含量为有效量至 5.5 x 10-6 当量(以离子当量计)。上述醋酸纤维素还可用于纺丝工艺。醋酸纤维素包括二醋酸纤维素和三醋酸纤维素。本发明的醋酸纤维素具有很高的从载体中释放薄膜的能力和优异的光学特性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸